Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b+ myeloid cells
Year: 2024
Type: article
Abstract: Cumulative evidence has established that Interferon (IFN)-γ has both pathogenic and protective roles in Multiple Sclerosis and the animal model, Experimental Autoimmune Encephalomyelitis (EAE). However, the underlying mechanisms to the beneficial effects of IFN-γ are not well understood. In this study, we found that IFN-γ exerts therapeutic effects on chronic, relapsing-remitting, and chronic progressive EAE models. The frequency of regulatory T (Treg) cells in spinal cords from chronic EAE mice treated with IFN-γ was significantly increased with no effect on Th1 and Th17 cells. Consistently, depletion of FOXP3-expressing cells blocked the protective effects of IFN-γ, indicating that the therapeutic effect of IFN-γ depends on the presence of Treg cells. However, IFN-γ did not trigger direct in vitro differentiation of Treg cells. In vivo administration of blocking antibodies against either interleukin (IL)-10, transforming growth factor (TGF)-β or program death (PD)-1, revealed that the protective effects of IFN-γ in EAE were also dependent on TGF-β and PD-1, but not on IL-10, suggesting that IFN-γ might have an indirect role on Treg cells acting through antigen-presenting cells. Indeed, IFN-γ treatment increased the frequency of a subset of splenic CD11b+ myeloid cells expressing TGF-β-Latency Associated Peptide (LAP) and program death ligand 1 (PD-L1) in a signal transducer and activator of transcription (STAT)-1-dependent manner. Furthermore, splenic CD11b+ cells from EAE mice preconditioned in vitro with IFN-γ and myelin oligodendrocyte glycoprotein (MOG) peptide exhibited a tolerogenic phenotype with the capability to induce conversion of naïve CD4+ T cells mediated by secretion of TGF-β. Remarkably, adoptive transfer of splenic CD11b+ cells from IFN-γ-treated EAE mice into untreated recipient mice ameliorated clinical symptoms of EAE and limited central nervous system infiltration of mononuclear cells and effector helper T cells. These results reveal a novel cellular and molecular mechanism whereby IFN-γ promotes beneficial effects in EAE by endowing splenic CD11b+ myeloid cells with tolerogenic and therapeutic activities.
Source: Journal of Neuroinflammation
Authors: Gabriel Arellano, Eric Acuña, Eileah Loda, Lindsay Moore, Juan E. Tichauer, Cristian Castillo, Fabian Vergara, Paula I. Burgos, Pablo Penaloza-MacMaster, Stephen D. Miller, Rodrigo Naves
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: interferon-gamma, experimental autoimmune encephalomyelitis, multiple sclerosis, regulatory T cells, Foxp3, tolerogenic antigen-presenting cells, TGF-beta, PD-1, IL-10, STAT1, PD-L1, myelin oligodendrocyte glycoprotein, adoptive transfer, neuroinflammation, Th17 cells, Th1 cells, immunomodulation
Open Access status: gold
Estimated APC paid: $3,790
Awards: ACTIVIDAD TOLEROGENICA DE INTERFERON-GAMMA SOBRE LA MICROGLIA EN UN MODELO EXPERIMENTAL DE NEUROINFLAMACION AUTOINMUNE., INTERFERON-GAMMA-INDUCED REGULATORY T CELL RESPONSE IS DEPENDENT ON PD-1/PD-L1 PATHWAY IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS AND MULTIPLE SCLEROSIS, G2283435683, G2915087881, INTERFERON-GAMMA-INDUCED ACTIVATION OF A REGULATORY T CELL SUBSET SPECIALIZED IN THESUPPRESSION OF EXPERIMENTAL AUTOINMMUNE ENCEPHALOMYELITIS AND MULTIPLE SCLEROSIS, G4594364446, Interferon-modulated vaccines against HIV, OBTENCION DE CITOMETRO DE FLUJO ACTIVADO POR FLUORESCENCIA PARA APOYAR LAS ACTIVIDADES DEL CENTRO AVANZADO PARA LA FORMACION E INVESTIGACION EN EL DISENO DE ESTRATEGIAS INMUNOLOGICAS PARA EL CONTROL DE AGRESIONES PARASITARIAS Y NEOPLASICAS, IMMUNOMODULATORY AND THERAPEUTIC ACTIVITY OF RESOLVIN E1 IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS AND MULTIPLE SCLEROSIS, G7997001674, G8021527252, VITAMIN D MODULATION OF TOLL-LIKE RECEPTOR EXPRESSION IN B CELLS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
OpenAlex ID: W4399208793
